tridemorph has been researched along with Precancerous Conditions in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Akama, MSK; Gallo, CB; Innocentini, LMAR; Motta, ACF; Pinheiro, TN; Ribeiro-Silva, A; Teixeira, LR | 1 |
Agarwal, S; Patil, S; Rahman, F; Rao, NN; Srivastava, S; Tippu, SR | 1 |
Chandu, A; McCullough, M; Rani, V | 1 |
Andriani, F; Fusenig, NE; Garfield, J; Garlick, JA | 1 |
Airola, K; Johansson, N; Kähäri, VM; Kariniemi, AL; Saarialho-Kere, UK | 1 |
Carter, WG; Dabelsteen, E; Reibel, J; Schiødt, M; Stenersen, TC; Therkildsen, MH; Thorup, AK | 1 |
Brown, R; Ellerbroek, SM; Ghosh, S; Jones, JC; Stack, MS | 1 |
7 other study(ies) available for tridemorph and Precancerous Conditions
Article | Year |
---|---|
Laminin-332 expression in oral lichen planus: Preliminary results of a cross-sectional study.
Topics: Cell Adhesion Molecules; Cell Transformation, Neoplastic; Cross-Sectional Studies; Humans; Kalinin; Laminin; Lichen Planus, Oral; Mouth Neoplasms; Precancerous Conditions | 2021 |
The expression of laminin-5 in severe dysplasia/carcinoma in situ and early invasive squamous cell carcinoma: an immunohistochemical study.
Topics: Basement Membrane; Biomarkers, Tumor; Carcinoma in Situ; Carcinoma, Squamous Cell; Case-Control Studies; Cell Adhesion Molecules; Humans; Kalinin; Mouth Mucosa; Mouth Neoplasms; Neoplasm Invasiveness; Neoplasm Proteins; Precancerous Conditions | 2013 |
Assessment of laminin-5 in oral dysplasia and squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Adhesion Molecules; Cell Nucleus; Cell Transformation, Neoplastic; Cyclin D1; Cytoplasm; Epithelium; Female; Humans; Hyperplasia; Image Processing, Computer-Assisted; Immunohistochemistry; Kalinin; Ki-67 Antigen; Laminin; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neoplasm Invasiveness; Precancerous Conditions | 2013 |
Basement membrane proteins promote progression of intraepithelial neoplasia in 3-dimensional models of human stratified epithelium.
Topics: 3T3 Cells; Animals; Basement Membrane; Carcinoma in Situ; Cell Adhesion; Cell Adhesion Molecules; Cell Division; Coculture Techniques; Collagen Type IV; Epithelial Cells; Fibroblasts; Humans; Kalinin; Keratinocytes; Laminin; Male; Mice; Mice, Nude; Organ Culture Techniques; Phenotype; Precancerous Conditions; Stromal Cells | 2004 |
Human collagenase-3 is expressed in malignant squamous epithelium of the skin.
Topics: Basement Membrane; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Adhesion Molecules; Collagen; Collagenases; Epithelium; Extracellular Matrix; Gene Expression; Genetic Markers; Head and Neck Neoplasms; Humans; Immunohistochemistry; Kalinin; Matrix Metalloproteinase 13; Matrix Metalloproteinase 3; Paget Disease, Extramammary; Precancerous Conditions; RNA Probes; RNA, Messenger; Skin; Skin Neoplasms | 1997 |
Can alterations in integrin and laminin-5 expression be used as markers of malignancy?
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Adhesion Molecules; Humans; Integrins; Kalinin; Leukoplakia, Oral; Middle Aged; Precancerous Conditions | 1998 |
Urinary-type plasminogen activator (uPA) expression and uPA receptor localization are regulated by alpha 3beta 1 integrin in oral keratinocytes.
Topics: Calcium-Calmodulin-Dependent Protein Kinases; Cell Adhesion Molecules; Cell Compartmentation; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation, Neoplastic; Gingiva; Humans; Integrin alpha3beta1; Integrins; Intercellular Junctions; Kalinin; Keratinocytes; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Phosphorylation; Plasminogen; Plasminogen Activator Inhibitor 1; Precancerous Conditions; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 2000 |